Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression (Q39262372)

10 September 2017

title

Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression (English)

1 reference

10 September 2017

1 reference

1 reference

Bin Zhang

1

1 reference

10 September 2017

Xia Zhang

2

1 reference

10 September 2017

Bo Tang

3

1 reference

10 September 2017

Peishi Zheng

4

1 reference

10 September 2017

Yang Zhang

5

1 reference

10 September 2017

language of work or name

English

0 references

publication date

30 September 2012

1 reference

Breast Cancer Research and Treatment

10 September 2017

published in

1 reference

10 September 2017

volume

136

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

399-406

1 reference

Acquired tamoxifen resistance in human breast cancer--potential mechanisms and clinical implications

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Endocrine-responsive breast cancer and strategies for combating resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Enhancing the efficacy of hormonal agents with selected targeted agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Down-regulation of survivin and hypoxia-inducible factor-1 α by β-elemene enhances the radiosensitivity of lung adenocarcinoma xenograft

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Expression of estrogen receptors alfa and beta mRNA and alkaline phosphatase in the differentiation of osteoblasts from elderly postmenopausal women: comparison with osteoblasts from osteosarcoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Linkage of Rapid Estrogen Action to MAPK Activation by ER -Shc Association and Shc Pathway Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Activation of mitogen-activated protein kinase in xenografts and cells during prolonged treatment with aromatase inhibitor letrozole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Histological and biological evolution of human premalignant breast disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Silencing of estrogen receptor alpha (ERalpha) gene by promoter hypermethylation is a frequent event in Chinese women with sporadic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2263-6

10.1007/S10549-012-2263-6

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference